BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee JL, Mohd Saffian S, Makmor-Bakry M, Islahudin F, Alias H, Noh LM, Ismail IH, Mohamed Shah N. Population pharmacokinetic modelling of intravenous immunoglobulin in patients with predominantly antibody deficiencies. Br J Clin Pharmacol 2021;87:2956-66. [PMID: 33377197 DOI: 10.1111/bcp.14712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Follman K, Freshwater E, Engler F, Yel L. Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies. International Immunopharmacology 2022;113:109331. [DOI: 10.1016/j.intimp.2022.109331] [Reference Citation Analysis]
2 Fokkink WJR, van Tilburg SJ, de Winter BCM, Sassen SDT, van Doorn PA, Koch BCP, Jacobs BC. Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain-Barré Syndrome. Clin Pharmacokinet 2022. [PMID: 35781631 DOI: 10.1007/s40262-022-01136-z] [Reference Citation Analysis]